Abstract
Cyclic GMP was first described in urine and other biological samples more than 25 years ago. The description and characterization of the enzymes responsible for cyclic GMP synthesis (guanylate cyclase), cyclic GMP hydrolysis (phosphodiesterase), and expression of some of the effects of cyclic GMP (cyclic GMP-dependent protein kinase) followed shortly thereafter. It soon became apparent that various hormones could increase cyclic GMP synthesis and accumulation in different tissues. Thus, it was anticipated that cyclic GMP would serve as a second messenger of many hormone-induced responses (see Murad 1986; Murad et al. 1978, 1979, 1988; Waldman and Murad 1987). However, the mechanisms of hormone-induced cyclic GMP accumulation in tissues and the coupling of hormone receptors to cyclic GMP synthesis have remained unresolved until the past several years. The major difficulties in answering these interesting questions are due to the multiple isoenzyme forms of guanylate cyclase, the diverse mechanisms of hormone-receptor coupling to the regulation of each of these isoenzymes, and the failure of hormones to activate the enzyme in cell-free preparations. The detailed characterization and purification of these isoforms of guanylate cyclase in our laboratory and others have permitted us to begin to understand the mechanisms of hormonal regulation of the guanylate cyclase isoenzyme family. Some of the properties of the isoforms of guanylate cyclase and the mechanisms of hormone-receptor coupling to each of these isoforms will be briefly reviewed here. Interestingly, the four isoenzyme forms of guanylate cyclase that have been described to date are each uniquely coupled to hormonal regulation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arnold, W.P., Mittal, C.K., Katuski, S. & Murad, F. (1977) Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA 74:3203–3207
Bohme, E., Graf, H. & Schultz, G. (1978) Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv. Cyclic Nucl. Res. 9:131–143
Chang, C.H., Kohse, K., Chang, B. & Murad, F. (1989) Participation of protein phosphorylation in the activation of particulate guanylate cyclase by ANP. FASEB Vol 3, Issue 4, A 1005
Chinkers, M., Garbers, D., Chang, M.S., Lowe, D., Chin, H.. Goeddel, D.V. & Schulz, S. (1989) A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature (London) 338:78–83
Deguchi, T. & Yoshioko, M. (1982) L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J. Biol. Chem. 257:10147–10151
Field, M., Graf, L.H., Laird, W.J. & Smith, P.L. (1978) Heat-stable enterotoxin of E. coli: in-vitro effects on guanylate cyclase activity, cyclic GMP concentration and ion transport in small intestine. Proc. Natl. Acad. Sci. USA 75:2800–2804
Furchgott, R.F. (1988) Studies on the relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and EDRF is nitric oxide. In: VanHoutte, P. (ed.) Mechanisms of vasodilation. Raven Press, New York 401–414
Guerrant, R.L., Hughes, J.M., Chang, B., Robertson, D.C. & Murad, F. (1980) Activation of intestinal guanylate cyclase by heat stable enterotoxin of Escherichia coli: studies of tissue specificity, potential receptors and intermediates. J. Infect. Dis. 142:220–228
Hibbs, J.D., Vavrin, Z. & Taintor, R.L. (1987) L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550–565
Hughes, J., Murad, F., Chang, B. & Guerrant, R. (1978) The role of cyclic GMP in the mechanism of action of heat-stable enterotoxin of E. coli. Nature (London) 271:755–756
Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E. & Chaudhuri, G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84:9265–9269
Ishii, K., Gorsky, L., Förstermann, V. & Murad, F. (1989) Endothelium-derived relaxing factor: the endogenous activator of soluble guanylate cyclase in various types of cells. J. Applied Cardiology (in press.)
Kamisaki, Y., Saheki, S., Nakane, M., Palmieri, J., Kuno, T., Chang, B., Waldman, S.A. & Murad, F. (1986) Soluble guanylate cyclase from rat lung exists as a heterodimer. J. Biol. Chem. 261:7236–7241
Katsuki, S. & Murad, F. (1977) Regulation of cyclic 3’,5’-adenosine monophosphate and cyclic 3’,5’guanosine monophosphate levels and contractility in bovine tracheal smooth muscle. Mol. Pharmacol. 13:330–341
Katsuki, S., Arnold, W., Mittal, C.K. & Murad, F. (1977) Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucl. Res. 3:23–25
Kuno, T., Andresen, J.W., Kamisaki, Y., Waldman, S.A., Chang, L.Y., Saheki, S., Leitman, D.C., Nakane, M. & Murad, F. (1986) Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J. Biol. Chem. 261:5817–5823
Kurose, H., Inagami, T. & Ui, M. (1987) Participation of adenosine 5’ triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor. FEBS Lett. 219:375–379
Leitman, D.C., Agnost, V.L., Catalano, R.M., Schroeder, H., Waldman, S.A., Bennett, B.M., Tuan, J.J. & Murad, F. (1988) Atrial natriuretic peptide, oxytocin and vasopressin increase cyclic GMP in LLC-PK, kidney epithelial cells. Endocrinology 122:1478–1485
Mittal. C.K. & Murad, F. (1977) Properties and oxidative regulation of guanylate cyclase. J. Cyclic Nucl. Res. 3:381–391
Mittal, C.K., Arnold, W.P. & Murad, F. (1978) Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung. J. Biol. Chem. 253:1266–1271
Moncada, S., Palmer, R.M.J. & Higgs, E.A. (1988) The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 12:365–372
Murad, F. (1986) Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78:1–5
Murad, F. (1989) Modulation of the guanylate cyclase-cyclic G MP system by vasodilators and the role of free radicals as second messengers. Proc. NATO Adv. Stud. Inst. Vascular endothelium: receptors and transduction mechanisms, Porto Carros, Greece June, 1988, in Vascular Endothelium eds J.D. Catrovos, C.N. Gillis and U.S. Ryan, Plenum Pub. 157–164
Murad, F. & Aurbach, G.D. (1978) Cyclic GMP in metabolism: interrelationship of biogenic amines, hormones and other agents. In: Freinkel, N. (ed.) The year in metabolism 1976–1977. Plenum, New York, pp 1–32
Murad, F., Mittal, C.K., Arnold, W.P., Katsuki, S. & Kimura, H. (1978) Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv. Cyclic Nucl. Res. 9:145–158
Murad, F., Arnold, W.P., Mittal, C.K. & Braughler, J.M. (1979) Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP. Adv. Cyclic Nucl. Res. 11:175–204
Murad, F., Leitman, D., Waldman, S., Chang, C.H., Hirata, M. & Kohse, K. (1988) Effects of nitrovasodilators, endothelium-dependent vasodilators and atrial peptides on cGMP. Cold Spring Harbor Symp. Quant. Biol. 53:1005–1009
Rapoport, R.M. & Murad, F. (1983) Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role for cyclic GMP. J. Cyclic Nucl. Protein Phosphor. Res. 9:281–296
Song, D.L., Kohse, K. & Murad, F. (1988) Brain natriuretic factor: augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding. FEBS Lett. 1:125–129
Waldman, S.A. & Murad, F. (1987) Cyclic GMP synthesis and function. Pharm. Rev. 39:163–196
Waldman, S.A., Rapoport, R.M. & Murad, F. (1984) Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J. Biol. Chem. 259:14332–14334
Waldman, S.A., Kuno, T., Kamisaki, Y., Chang, L.Y., Garieppy, J., O’Hanley, P.D., Schoolnik, G.K. & Murad, F. (1986) Intestinal receptor for heat-stable enterotoxin of E. Coli is tightly coupled to a novel form of particulate guanylate cyclase. Inf. Immunol. 51:320–326
Waldman, S.A., Leitman, D.C., Chang, L.Y. & Murad, F. (1989) Comparison of particulate guanylate cyclase in cells with and without atrial natriuretic peptide receptor binding activity Mol. Cell. Biochem. (in press).
Winquist, R.M., Faison, E.P., Waldman, S.A., Schwartz, K., Murad, F. & Rapoport, R.M. (1984) Atrial natriuretic factor elicits an endothelium independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc. Natl. Acad. Sci. 81:7661–7664
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Murad, F. (1989). Mechanisms for Hormonal Regulation of the Different Isoforms of Guanylate Cyclase. In: Gehring, U., Helmreich, E.J.M., Schultz, G. (eds) Molecular Mechanisms of Hormone Action. 40. Colloquium der Gesellschaft für Biologische Chemie 6.– 8. April 1989 in Mosbach/Baden, vol 40. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75022-9_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-75022-9_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75024-3
Online ISBN: 978-3-642-75022-9
eBook Packages: Springer Book Archive